NLRP3 and type 2 diabetes mellitus: In addition, NLRP3 inflammasome activation and production of IL-1β are upregulated in the peripheral mononuclear cells of drug-naïve type-2 diabetic patients, suggesting a role of the inflammasome in the pathogenesis of type-2 diabetes [128].